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Consider Turkey before 2008.
Nearly half of all men smoked, as did nearly one out of every six women— among 
the highest rates in the world. Cigarettes were lit at business meetings, on buses and 
in Parliament. Restaurants and hotels were perpetually shrouded in a dingy, 
choking haze.
Cigarettes were considered a polite hospitality gift when visiting friends and family. And, 
perhaps most shocking of all, nearly a third of Turkish smokers started before the age of 10, 
according to a 2003 survey. Smoking flavored tobacco in a water pipe is a tradition that 
dates back to the 17th century under the Ottoman Empire.
Then came a health revolution. In December 2007, Turkish Prime Minister Recep Tayyip 
Erdogan declared the fight against tobacco to be “as important as our counterterrorism 
struggle.” He told a meeting of the National Tobacco Control Program in Ankara that 
tobacco products were “literally murdering our future generations.” Less than a month later, 
he signed a law banning smoking in all enclosed public spaces. It was part of a 
comprehensive effort involving government, advocacy groups, universities and nonprofit 
organizations to reduce tobacco-related diseases, which had accounted for more than 20 
percent of admissions and half of deaths at Turkish hospitals at the turn of the millennium. 
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Other policy measures included a stiff 81 percent tax on tobacco products, a total ban on 
cigarette advertising and promotion, warning labels on packages and government-funded 
quit-smoking programs. On Turkish television, a filter blurred out cigarettes held by actors 
on-screen.
Results came fast. “In just one year, between 2009 and 2010, admissions to hospital 
emergency rooms for smoking-related disease decreased by 24 percent,” says Toker 
Erguder, a physician and National Tobacco Control Program officer for the World Health 
Organization (WHO) in Turkey. “It demonstrates that policies to control tobacco work, and 
if they work in Turkey, with our strong smoking culture, they can work anywhere in the 
world.”
Turkish Prime Minister Recep Tayyip Erdogan told a meeting of the National 
Tobacco Control Program in Ankara that tobacco products were “literally 
murdering our future generations.”
We tend to think of cardiovascular ailments as diseases of lifestyle because their 
development and progression are influenced by what appears to be individual personal 
choices: Whether we smoke, what we choose to eat, how much we exercise and other 
factors. But those personal choices are heavily swayed by our environment and by our 
options. And—as Turkey’s experience shows—public policy is a powerful tool for shaping 
that environment. It’s no wonder, then, that in its report, “Promoting Cardiovascular Health 
in the Developing World,” the U.S. Institute of Medicine urged that policy be used to 
promote cardiovascular health around the globe.
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A wide range of government policies have been used to protect people from cardiovascular 
diseases. Taxes, for example, are a powerful force for discouraging high-risk behaviors. 
Raising taxes on cigarettes is often a foundational part of any national antitobacco 
campaign. That strategy is now being applied in the fight against obesity. In Mexico, which 
recently surpassed the U.S. with the world’s highest prevalence of obesity, legislators 
approved a national levy of one peso per liter on sugar-sweetened beverages (about 10 
percent) as well as an 8 percent tax on junk food (foods that contain 275 calories or more per 
100 grams).
Subsidizing what’s good may be as important as taxing what’s bad, such as government 
support for quit smoking or healthy diet programs. In Mexico, that includes federal spending 
to install water fountains in public schools to ensure a cost-free, healthful alternative to soda.
Including efforts such as these within a well thought-out, larger strategy is an effective way 
for policy makers to help make the healthier choice the easier choice across an entire 
population, reducing the risk for heart disease and stroke and leading to improved health and 
lives saved. This approach has proven successful in high-income countries and is now being 
rolled out in middle- and low-income nations to combat the world’s two biggest causes of 
cardiovascular mortality: tobacco use and high blood pressure.
An “MPOWERED” APPROACH TO TOBACCO POLICY
Tobacco is responsible for 9 percent of all deaths world-wide, killing six million people a 
year, mostly from cardiovascular diseases, cancer and chronic lung diseases. High-income 
countries currently bear a greater burden than middle- and low-income countries, with 18 
percent, 11 percent and 4 percent of all deaths, respectively. That’s because tobacco use 
peaked in wealthier countries several decades ago, and it typically takes 30 to 40 years for 
smoking to do fatal harm. But that ratio will shift in coming years, with rising tobacco use 
and population growth in less wealthy countries and decreasing use in more affluent nations. 
By 2030, tobacco-related diseases will kill eight million people a year, more than half of 
them in developing nations. These diseases are expected to claim a billion lives this century
—with about 70 percent in the developing world.
In May 2003, WHO took unprecedented action, passing the Framework Convention on 
Tobacco Control on behalf of its member states, the world’s first public health treaty. 
Reflecting decades of careful evaluation of interventions conducted in various locales, the 
WHO framework provides a foundation to successfully reduce tobacco use. As of June 15, 
2013, 178 countries had signed on. To support their commitment, WHO introduced 
MPOWER, a package of six tobacco-control measures. The acronym defines the strategy: 
Monitor tobacco use and prevention policies (with rigorous oversight and metrics); Protect 
people from tobacco smoke (generally with policies that limit or ban smoking in public 
spaces and indoors); Offer help to quit tobacco use (through cessation programs, hotlines 
and medications); Warn people about the dangers of tobacco (with labels on cigarette 
packages and health promotion campaigns); Enforce bans on tobacco advertising, promotion 
and sponsorship; and lastly, Raise taxes on tobacco. Together, these measures create an 
environment where not smoking or quitting is an easier choice to make.
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Turkey has implemented these policies more thoroughly than any other nation, according to 
a 2013 WHO analysis, and New York has done the best job of any major city. After all six 
MPOWER strategies were adopted there, adult smoking declined from 22 percent in 2002 to 
14 percent in 2010, with far fewer young people lighting up, down from nearly 18 percent to 
8 percent—a record drop.
MPOWER is gaining momentum: More than one third of the world’s population—2.3 
billion people in 92 countries—are now covered by at least one of its six measures. Nearly 
7.5 million smoking-related deaths will be averted because of MPOWER policies adopted in 
41 countries between 2007 and 2010.
Major funding for tobacco-control efforts in developing countries comes from Bloomberg 
Philanthropies, which has committed more than $600 million since 2007. Meanwhile, the 
U.S. Centers for Disease Control and Prevention (CDC) provides technical support in 180 
nations, collecting country-level information on tobacco use, interventions and evaluates the 
public’s awareness of the risks. The world’s most populous countries—China and India—
have made major commitments to MPOWER policies, along with Russia, where 40 percent 
of adults smoke and where one of the world’s toughest tobacco-control laws went into effect 
in June 2013.
LOWERING BLOOD PRESSURE WITH POLICY
High blood pressure is responsible for massive disability and huge numbers of 
cardiovascular-related deaths globally. It’s astonishingly common. Approximately one third 
of adults age 25 and older have high blood pressure, defined by doctors as having a systolic 
pressure (the pressure in the arteries when the heart beats) at or above 140 millimeters of 
mercury and/or a diastolic pressure (when the heart is resting between beats and refilling 
with blood) at or above 90 mm. In parts of Africa, Asia and eastern Europe, prevalence 
exceeds 45 percent.
High blood pressure, also called hypertension, puts a steady strain on blood vessels, 
resulting in damage that may cause them to narrow and harden with plaque. It raises the risk 
that vessels will break or that clots will form, break loose and cut off circulation to the brain, 
resulting in a stroke—or block blood flow to the heart, causing a heart attack. About one 
half of all heart attack and stroke deaths worldwide are linked to hypertension—causing 
over nine million largely preventable deaths each year. The financial toll is staggering: about 
$370 billion in 2001, the most recent comprehensive estimate. That’s more than 10 percent 
of the world’s health care spending.
Governments can play an important role in helping to reduce hypertension risks among their 
citizens. Due to the effect of sodium intake on blood pressure, policies are increasingly 
focused on reining in excessive consumption of salt (sodium chloride). Most people, 
regardless of race or nationality, consume too much, exceeding WHO recommended levels: 
2,000 milligrams of sodium daily or five grams of salt (about four fifths of a teaspoon). In 
many Asian countries, average intake is more than twice that level. According to an analysis 
led by Perviz Asaria of Imperial College London, reducing sodium intake by just 15 percent 
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in 23 low- and middle-income countries where hypertension is rampant could prevent 8.5 
million deaths over a 10-year period.
Although there is no precise equivalent to MPOWER when it comes to battling 
hypertension, an array of effective policies can work to change the trajectory. These 
policies, however, are best customized, as sodium intake varies greatly according to regional 
diet and reliance on packaged food. In high-income countries where processed foods are a 
common part of the daily diet, three quarters of salt comes from packaged and restaurant 
foods, while in other countries, nearly that much salt is added during cooking or at the table. 
In more economically developed countries, improvement has come through reducing salt in 
processed foods by clearly labeling sodium content on packages, making more healthful 
options available in the marketplace and using public programs to educate consumers. 
Finland pioneered the approach in the late 1970s, a protocol that reduced salt consumption 
by one third. The result: The average systolic blood pressure dropped by 10 mm over the 
next 30 years and death from both coronary heart disease and stroke fell by 75 percent.
In the United Kingdom, the government is working closely with food manufacturers to 
voluntarily lower salt content in 85 categories of processed and packaged foods. 
“Reformulation of mass-market products was the foundation for the most successful 
nutrition policy in the U.K. since the Second World War: The salt reduction programme that 
has cut the average national intake by 16 percent in its first six years,” noted J. T. Winkler, a 
British nutrition policy expert, in the British Medical Journal.
The approach has been adopted in the United States through the National Salt Reduction 
Initiative, and by the governments of Canada, Australia, Brazil and Colombia, among others. 
While the U.K. has shown that reducing population-wide sodium intake will require changes 
in the food supply at large, a pilot study in Argentina suggests that even small changes can 
make a difference: Just cutting the salt content in French bread from 2 percent to 1.4 percent 
sparked moderate reductions in average blood pressure.
In countries like China, where 80 percent of salt is added during cooking, other approaches 
may be appropriate. A 2011 survey found that about one quarter of adults in the northeastern 
province of Shandong had high blood pressure; average salt consumption was 12.5 grams 
per day. And yet, just one in four people was aware of the risks of a high-salt diet. In 2011, 
Shandong leaders and the national health ministry introduced a comprehensive salt reduction 
program, with technical support from the Chinese Center for Disease Control and Prevention 
in Bejing and the U.S. CDC. Their objective: reducing salt intake to 10 grams a day by 2015 
and providing better treatment for those with high blood pressure. The program includes 
classes in public schools, messages that are broadcast on television and on posters placed in 
restaurants and supermarkets. It also targets those who prepare food, with training for chefs 
and food service employees on preparing low-salt recipes and distribution of special spoons 
to individual households that measure out two or three grams of salt. Salt content in food 
now appears on food labels, there are new low-salt food aisles in grocery stores and the 
health department is working with doctors to improve the detection and treatment of 
hypertension.
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A preliminary assessment of the program’s impact is expected later this year, with more 
complete results due in 2015. “We are convinced that the salt reduction project will decrease 
the risk of hypertension among Shandong residents in a short time, and lower cardiovascular 
mortality in the long term,” says Wang Linhong, executive deputy director of China’s 
National Center for Chronic and Noncommunicable Disease Control and Prevention. “The 
experience in Shandong should be of value to the rest of China.”
To be comprehensive, programs also may include easy access to diagnosis, treatment and 
follow-up care for those with high blood pressure. This is a major challenge—even in 
economically developed countries. Effective treatment generally requires prescription drugs 
and long-term monitoring to ensure that patients reach and maintain a healthy blood 
pressure. In the U.S., only about half of those with hypertension have it under control, while 
in China—home to almost a fifth of the world’s population—only about 19 percent of 
people with hypertension have stabilized their blood pressure.
A new global initiative seeks to develop a standardized, affordable framework for treatment 
that can be adapted for use anywhere. That initiative, the Global Standardized Hypertension 
Treatment Project, is currently being launched by the U.S. CDC in collaboration with the 
Pan American Health Organization and other regional and international partners. It builds on 
approaches that proved previously successful in treating infectious diseases, such as those 
used to treat tuberculosis and HIV/AIDS. Managing these diseases also requires regular 
monitoring and lifelong adherence to medication as well as standardizing the specific 
medications used to treat them and promoting reliable data collection and patient 
management systems. Much of this is achieved by increased involvement of nurses.
Proof of concept comes from a 2013 study published in The Journal of the American 
Medical Association: This approach enabled doctors in the Kaiser Permanente health system 
to nearly double the numbers of patients with controlled hypertension in northern California. 
Creating comprehensive registries to track patient data, simplifying and standardizing 
treatment protocols and rigorous monitoring of clinical practices were all key to success, 
said Marc Jaffe, who heads the Kaiser Northern California Cardiovascular Risk Reduction 
Program. “Conceptually, this is easy, but to get it done takes a lot of persistence and 
strategy,” said Jaffe, who is now advising the CDC on the new global hypertension project.
And it’s not just high-income countries that can use this approach. Malawi, for example, has 
partnered with nonprofit organizations to manage hypertension, diabetes and other chronic 
diseases at a clinic that originally focused on HIV. That facility, which serves 50,000 people 
on the outskirts of the capital, Lilongwe, now treats HIV patients two days a week and those 
with noncommunicable diseases three days a week. The intake room is equipped with a 
touch-screen computer that makes care management and data collection easy. “We are using 
the same computer system and the same infrastructure for chronic care as for HIV,” said 
Anthony D. Harries, a senior advisor to the International Union Against Tuberculosis and 
Lung Disease, who also advises the Malawi Ministry of Health on the project.
The clinic will use a streamlined approach to treating hypertension that is similar to the 
Kaiser Permanente model. A low-cost diuretic is the first-line treatment with calcium 
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channel blockers and low-cost ACE (angio-tensin-converting enzyme) inhibitors added if 
needed. “It is very standardized,” Harries said. “We think this is the way forward, and my 
feeling is that if it can work in Malawi, which is one of the poorest countries in the world, it 
can work anywhere.” Both Harries and the national health ministry will be evaluating the 
program’s efficacy over the next few years, with a view toward replicating it throughout the 
country.
The rising tide of cardiovascular diseases in low- and middle-income countries threatens not 
only the health of their citizens, but also endangers their economic future. Over the last 
decade we have increased our knowledge of effective interventions that address 
cardiovascular health by lowering risk and has made healthy choices—such as avoiding 
tobacco and limiting sodium—much easier to make. In some cases, less developed countries 
may have an opportunity to avoid some of the woes that plague high-income countries—for 
example, by ensuring that high-fat, high-salt processed foods don’t become a mainstay of 
local diets. Disseminating lessons learned from innovative policies, such as China’s salt 
reduction program to prevent and reduce hypertension, Malawi’s approach to treating 
hypertension and Turkey’s implementation of MPOWER may share lifesaving lessons 
across the globe that improve cardiovascular health and curtail its risk factors.
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Prevalence of Raised Blood Pressures,* Ages 25+, Age Standardized, Both Sexes, 2008
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Number of Current Smokers among Adults and High School Students in New York City, 
1997–2011 (Percentage)
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SOURCES OF SODIUM IN CHINA AND U.S.
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